Enrique Lores - 12 Sep 2024 Form 4 Insider Report for HP INC (HPQ)

Role
President and CEO, Director
Signature
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores
Issuer symbol
HPQ
Transactions as of
12 Sep 2024
Net transactions value
-$989,825
Form type
4
Filing time
13 Sep 2024, 17:03:30 UTC
Previous filing
17 Jan 2025
Next filing
22 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HPQ Common Stock Options Exercise $6,023,548 +211,501 +7050033% $28.48 211,504 12 Sep 2024 Direct
transaction HPQ Common Stock Sale $7,013,373 -211,501 -100% $33.16 3 12 Sep 2024 Direct F1, F2
holding HPQ Common Stock 888,908 12 Sep 2024 By Limited Partnership F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Performance Contingent Stock Options Options Exercise $0 -211,501 -33% $0.000000 423,002 12 Sep 2024 Common Stock 211,501 $28.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/10/2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.96-$33.40, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Represents shares held by a limited partnership, which is ultimately controlled by the reporting person.
F4 On 12/8/2022, the reporting person was granted 634,503 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.